You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Patient selection for CAR T or BiTE therapy in multiple myeloma: Which treatment for each patient?
|
|---|---|
| Published in |
Journal of Hematology & Oncology, June 2022
|
| DOI | 10.1186/s13045-022-01296-2 |
| Pubmed ID | |
| Authors |
David Kegyes, Catalin Constantinescu, Louise Vrancken, Leo Rasche, Celine Gregoire, Bogdan Tigu, Diana Gulei, Delia Dima, Alina Tanase, Hermann Einsele, Stefan Ciurea, Ciprian Tomuleasa, Jo Caers |
X Demographics
The data shown below were collected from the profiles of 17 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 12% |
| India | 1 | 6% |
| Spain | 1 | 6% |
| France | 1 | 6% |
| Algeria | 1 | 6% |
| Thailand | 1 | 6% |
| Unknown | 10 | 59% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 15 | 88% |
| Scientists | 2 | 12% |
Mendeley readers
The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 49 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Professor | 5 | 10% |
| Unspecified | 4 | 8% |
| Student > Bachelor | 3 | 6% |
| Researcher | 3 | 6% |
| Student > Master | 2 | 4% |
| Other | 5 | 10% |
| Unknown | 27 | 55% |
| Readers by discipline | Count | As % |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 14% |
| Medicine and Dentistry | 5 | 10% |
| Unspecified | 4 | 8% |
| Immunology and Microbiology | 3 | 6% |
| Biochemistry, Genetics and Molecular Biology | 1 | 2% |
| Other | 1 | 2% |
| Unknown | 28 | 57% |
Attention Score in Context
This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 January 2023.
All research outputs
#3,372,927
of 25,243,120 outputs
Outputs from Journal of Hematology & Oncology
#297
of 1,284 outputs
Outputs of similar age
#71,457
of 438,728 outputs
Outputs of similar age from Journal of Hematology & Oncology
#19
of 49 outputs
Altmetric has tracked 25,243,120 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,284 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.4. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 438,728 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 49 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.